Stocks
United Therapeutics CorporationUTHR
NASDAQHealthcareBiotechnology$536.12+0.62%
A biotechnology company focused on developing and commercializing therapies for pulmonary arterial hypertension and other rare diseases. Its revenue is largely driven by a portfolio of PAH treatments, while the company invests heavily in next‑generation platforms including organ manufacturing and re...
Market Cap: $23.5B52W Range: $266.98 – $548.12
Congressional Interest in United Therapeutics Corporation (UTHR)
6 members of Congress have disclosed 36 trades in United Therapeutics Corporation (UTHR), a Healthcare company. The buy/sell breakdown shows 22 purchases versus 14 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
36
Unique Politicians
6
Buys
22
Sells
14
Who in Congress Is Trading UTHR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-10-31 | Lisa McClain | sell | $1K – $15K |
| 2025-10-30 | Lisa McClain | sell | $1K – $15K |